fda tirzepatide shortage resolved october 2 2024 reconsidering its decision to take off its drug list 2024 Ends With Lilly's Landmark

Why Choose GLP-1 Injectables

Four in five users (81%) said prescriber-led, personalized care would improve their journey

Careful consideration of individual patient needs is crucial

Public-facing trust centers (as WaitWell publishes) shorten the IT and compliance review cycle

Burst C Rating (Discharge) In addition to the constant C rating, there is also a burst C rating, which is higher

So after the recent publication of a study indicating that statins can have a detrimental effect on GLP-1 secretion and insulin sensitivity, an important question quickly followed: should individuals on statins be concerned about these apparent effects on metabolic health